Association Between Vericiguat and Clinical Outcomes Across Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Background: Heart failure (HF) remains a major global health burden, with mortality continuing to rise despite therapeutic advances. Vericiguat, a soluble guanylate cyclase stimulator, has demonstrated potential benefit in patients with worsening HF with reduced ejection fraction...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
IMR Press
2026-04-01
|
| Colección: | Reviews in Cardiovascular Medicine |
| Materias: | |
| Acceso en línea: | https://www.imrpress.com/journal/RCM/27/4/10.31083/RCM49095 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|